Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
Cocrystal Pharma (Nasdaq: COCP) has announced its participation in the upcoming Life Science Innovation Northwest (LSINW) 2025 Conference. Sam Lee, President and co-CEO, will deliver a company overview presentation on Wednesday, April 23, 2025 at 3:00 p.m. Pacific time. The conference will take place at the Seattle Convention Center from April 23-24.
Cocrystal Pharma (Nasdaq: COCP) ha annunciato la sua partecipazione alla prossima Life Science Innovation Northwest (LSINW) 2025 Conference. Sam Lee, presidente e co-amministratore delegato, terrà una presentazione panoramica sull'azienda mercoledì 23 aprile 2025 alle 15:00 ora del Pacifico. La conferenza si svolgerà al Seattle Convention Center dal 23 al 24 aprile.
Cocrystal Pharma (Nasdaq: COCP) ha anunciado su participación en la próxima Life Science Innovation Northwest (LSINW) 2025 Conference. Sam Lee, presidente y co-CEO, ofrecerá una presentación general de la empresa el miércoles 23 de abril de 2025 a las 3:00 p.m., hora del Pacífico. La conferencia se llevará a cabo en el Seattle Convention Center del 23 al 24 de abril.
Cocrystal Pharma (나스닥: COCP)가 다가오는 Life Science Innovation Northwest (LSINW) 2025 컨퍼런스에 참여한다고 발표했습니다. Sam Lee 사장 겸 공동 CEO가 2025년 4월 23일 수요일 오후 3시 태평양 시간에 회사 개요 발표를 진행할 예정입니다. 컨퍼런스는 시애틀 컨벤션 센터에서 4월 23일부터 24일까지 열립니다.
Cocrystal Pharma (Nasdaq : COCP) a annoncé sa participation à la prochaine Life Science Innovation Northwest (LSINW) 2025 Conference. Sam Lee, président et co-CEO, présentera un aperçu de l’entreprise le mercredi 23 avril 2025 à 15h00, heure du Pacifique. La conférence se tiendra au Seattle Convention Center du 23 au 24 avril.
Cocrystal Pharma (Nasdaq: COCP) hat seine Teilnahme an der kommenden Life Science Innovation Northwest (LSINW) 2025 Konferenz angekündigt. Sam Lee, Präsident und Co-CEO, wird am Mittwoch, den 23. April 2025 um 15:00 Uhr Pazifikzeit eine Unternehmensübersicht präsentieren. Die Konferenz findet vom 23. bis 24. April im Seattle Convention Center statt.
- None.
- None.
BOTHELL, Wash., April 16, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest (LSINW) 2025 Conference on Wednesday, April 23, 2025 at 3:00 p.m. Pacific time. The conference is being held April 23-24 at the Seattle Convention Center.
About Life Science Innovation Northwest
Life Science Innovation Northwest (LSINW) is the Pacific Northwest’s largest annual life science conference. This event brings together investors, public and private life science organizations, research institutions, scientists, entrepreneurs, and the global health community to discuss and feature some of the most compelling life science breakthroughs of our time. Bringing together over 700 attendees, LSINW features 80+ company and research institution presentations, keynote addresses from industry leaders, engaging panel discussions on emerging trends, a dynamic startup fast pitch showdown, insightful poster presentations, and more - making it the must-attend event for the PNW’s life science community. More information is available here.
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.
Contact:
Alliance Advisors IR
Jody Cain
310-691-7100
jcain@allianceadvisors.com
# # #
